A kind of chroman derivative and its preparation method and application
A derivative, chroman technology, applied in the field of pharmacy, to achieve the effects of novel structure, improvement of intestinal microecological disorder, and excellent anti-alcoholic fatty liver disease activity in vivo
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0085] 8',8'-Dimethyl-1-(7-methyl-1H-indole-5-carbonyl)-7',8'-dihydro-6'H-spiro[piperidine-4,2' -pyrone[3,2-g]benzopyran]-4'(3'H)-one (I-1),
[0086]
[0087] Step 1) 1-(7-Hydroxy-2,2-dimethylchroman-6-yl) ethyl ketone
[0088] Put 8g (52.80mmol) of 2,4-dihydroxyacetophenone and 150mL of 1,4-dioxane into a 250mL three-necked flask, and stir at room temperature until completely dissolved. Add 11.20 mL (0.11 mol) boron trifluoride ether solution drop by drop, and stir at room temperature until the solution turns pink. Then, 7.19 g (0.11 mol) of isoprene in 1,4-dioxane (25 mL) was added dropwise, and the solution turned purple-black, and stirred overnight at room temperature. After the reaction was detected by TLC, saturated ammonium chloride solution (50mL) was added to the reaction solution, extracted with ethyl acetate (60mL×3), the organic phases were combined, and the organic phase was washed with saturated sodium chloride solution (50mL). It was dried over sodium sulf...
Embodiment 2
[0097] 8',8'-Dimethyl-1-(2-phenyl-1H-benzimidazole-5-carbonyl)-7',8'-dihydro-6'H-spiro[piperidine-4,2 '-Pyrone[3,2-g]benzopyran]-4'(3'H)-one (I-2)
[0098]
[0099] The synthesis procedure was the same as in Example 1, and 69 mg of white solid was obtained, with a melting point of 219-221° C. and a yield of 77%.
[0100] 1 H NMR (300MHz, DMSO-d 6 )δ13.05(s,1H),8.35–8.21(m,1H),7.87–7.69(m,3H),7.60(d,J=9.1Hz,3H),7.50(s,1H),7.25(d ,J=8.3Hz,1H),6.34(s,1H),4.21(s,2H),3.69(s,2H),2.81–2.64(m,4H),1.92(s,2H),1.84–1.71( m,4H),1.29(s,6H).MS(ESI)m / z: calculated for C 32 h 31 N 3 o 4 [M-H] - :520.2, found: 520.2.
Embodiment 3
[0102] 8',8'-Dimethyl-1-(7-methyl-2-propyl-1H-benzimidazole-5-carbonyl)-7',8'-dihydro-6'H-spiro[piper Pyridine-4,2'-pyrone[3,2-g]benzopyran]-4'(3'H)-one (I-3)
[0103]
[0104] The synthesis steps were the same as in Example 1, and 70 mg of white solid was obtained, with a melting point of 175-177° C. and a yield of 70%.
[0105] 1 H NMR (300MHz, DMSO-d 6 )δ12.19(s,1H),7.49(s,1H),7.34(s,1H),6.98(s,1H),6.33(s,1H),4.17(s,2H),2.80(t,J =7.5Hz,2H),2.72(d,J=8.9Hz,4H),2.49(s,3H),2.01–1.63(m,8H),1.29(s,6H),0.94(t,J=7.4Hz ,3H).MS(ESI)m / z: calculated for C 30 h 35 N 3 o 4 [M+Na] + :524.3,found:524.3.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


